Institutional investors control 8.74% of the outstanding shares in ROSG. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended December 2016, these large investors purchased a net $14.5 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MORGAN STANLEY & CO. LLC Bought 68.3 Thousand shares of Rosetta Genomics Ltd
CREATIVE PLANNING, INC. Sold 117.00 shares of Rosetta Genomics Ltd